Early switch from IV to oral antibiotic treatment in bone and joint infections.

Sendi, Parham; Lora-Tamayo, Jaime; Cortes-Penfield, Nicolas W; Uçkay, Ilker (2023). Early switch from IV to oral antibiotic treatment in bone and joint infections. Clinical microbiology and infection, 29(9), pp. 1133-1138. Elsevier 10.1016/j.cmi.2023.05.008

Preview

Text 1-s2.0-S1198743X2300232X-main.pdf - Accepted Version Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (526kB) | Preview

OBJECTIVES

The timing of the switch from intravenous (IV) to oral antibiotic therapy for orthopaedic bone and joint infections (BJI) is debated. In this narrative article, we discuss the evidence for and against an early switch in BJIs.

SOURCES

We performed a PubMed and Internet search investigating the association between the duration of IV treatment for BJI and remission of infection among adult orthopaedic patients.

CONTENT

Among eight randomized-controlled trials and multiple retrospective studies, we failed to find any minimal duration of postsurgical IV therapy associated with clinical outcome. We did not find scientific data to support the prolonged use of IV therapy or to inform a minimal duration of IV therapy. Growing evidence supports the safety of an early switch to oral medications once the patient is clinically stable.

IMPLICATIONS

Following surgery for BJI, switch to oral antibiotics within a few days is reasonable in most cases. We recommend making the decision on the time point based on clinical criteria and in an interdisciplinary team at the bedside.

Interest & Impact

Downloads

58 since deposited on 15 May 2023
58 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item